‘Dual-target’ CAR-T cell therapy shrinks brain tumours
Targeting two brain tumour-associated proteins – rather than one – with CAR-T cell therapy has shown promise as a strategy for reducing solid tumour growth in patients with recurrent glioblastoma (GBM). This is according to early results from the first six patients treated in an ongoing… Read More